Growth Metrics

Mirum Pharmaceuticals (MIRM) Other Operating Expenses (2021 - 2025)

Mirum Pharmaceuticals has reported Other Operating Expenses over the past 5 years, most recently at $28.3 million for Q4 2025.

  • Quarterly results put Other Operating Expenses at $28.3 million for Q4 2025, up 24.07% from a year ago — trailing twelve months through Dec 2025 was $100.2 million (up 22.78% YoY), and the annual figure for FY2025 was $100.2 million, up 22.78%.
  • Other Operating Expenses for Q4 2025 was $28.3 million at Mirum Pharmaceuticals, up from $25.5 million in the prior quarter.
  • Over the last five years, Other Operating Expenses for MIRM hit a ceiling of $28.3 million in Q4 2025 and a floor of $1.9 million in Q4 2021.
  • Median Other Operating Expenses over the past 5 years was $17.8 million (2024), compared with a mean of $14.3 million.
  • Biggest five-year swings in Other Operating Expenses: soared 456.74% in 2023 and later decreased 8.95% in 2024.
  • Mirum Pharmaceuticals' Other Operating Expenses stood at $1.9 million in 2021, then skyrocketed by 136.15% to $4.5 million in 2022, then soared by 456.74% to $25.0 million in 2023, then dropped by 8.95% to $22.8 million in 2024, then increased by 24.07% to $28.3 million in 2025.
  • The last three reported values for Other Operating Expenses were $28.3 million (Q4 2025), $25.5 million (Q3 2025), and $23.4 million (Q2 2025) per Business Quant data.